Risk factors of mortality for patients receiving venovenous extracorporeal membrane oxygenation for COVID-19 acute respiratory distress syndrome

ZR Bergman, JK Wothe, FS Alwan, AE Lofrano… - Surgical …, 2021 - liebertpub.com
Background: Venovenous extracorporeal membrane oxygenation (VV-ECMO) for select
adults with severe acute respiratory distress syndrome (ARDS) cause by coronavirus …

[PDF][PDF] Extracorporeal membrane oxygenation (ECMO) dependent acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis

DB Shrestha, YR Sedhai, P Budhathoki, S Gaire… - Cureus, 2022 - cureus.com
Background: Extracorporeal membrane oxygenation (ECMO) has emerged as a newer
method for managing severe acute respiratory distress syndrome (ARDS) and ARDS …

[PDF][PDF] Extracorporeal membrane oxygenation (ECMO) for COVID-19 patients: ECMO for COVID-19

S Tongyoo, S Kongsayreepong - Clinical Critical Care, 2021 - scholar.archive.org
During the current outbreak of coronavirus disease 2019 (COVID-19), Extracorporeal
Membrane Oxygenation (ECMO) support could be considered as the rescue treatment from …

[HTML][HTML] Survival Outcome in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Support: Early Experience from a University Hospital in Thailand

P Duangpakdee, S Sakkarat… - The Surgery …, 2023 - thieme-connect.com
Objective Extracorporeal membrane oxygenation (ECMO) is a relatively new technology
used for life support in patients with cardiopulmonary failure from various causes. The …